G. Walsh

J. North, A. Kay, R. Sehmi, 1993, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Allergy and Asthma

G. Walsh, 2012 .

Emerging drugs for asthma

G. Walsh, 2008, Expert opinion on emerging drugs.

IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.

A. Wardlaw, A. Kay, K. Kurihara, 1990, Immunology.

Recent Developments in Targeting Eosinophil Accumulation as a Novel Therapeutic Approach for Asthma

A. J. Robinson, Ping Wu, G. Walsh, 2008 .

Statins as emerging treatments for asthma and chronic obstructive pulmonary disease

G. Walsh, 2008, Expert review of respiratory medicine.

Dupilumab utility in difficult-to-treat asthma.

G. Walsh, 2019 .

Anti-IL-4/-13 based therapy in asthma

G. Walsh, 2015, Expert opinion on emerging drugs.

Reduced eosinophil apoptosis in induced sputum correlates with asthma severity

G. Walsh, M. Blaylock, A. Lawrie, 2003, European Respiratory Journal.

Eosinophil Apoptosis and Clearance in Asthma

G. Walsh, 2013, Journal of cell death.

MECHANISMS OF STEROID ACTION AND RESISTANCE IN INFLAMMATION Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inﬂammation in asthma

D. Sexton, G. Walsh, M. Blaylock, 2003 .

Advances in the immunobiology of eosinophils and their role in disease.

G. Walsh, G. M. Walsh, 1999, Critical reviews in clinical laboratory sciences.

Human eosinophils: their accumulation, activation and fate

G. Walsh, 1997, British journal of haematology.

Eosinophil overview: structure, biological properties, and key functions.

H. Rosenberg, Paige Lacy, G. Walsh, 2014, Methods in molecular biology.

Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4).

A. Wardlaw, A. Kay, O. Cromwell, 1994, Immunology.

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma

G. Walsh, 2013, Biologics : targets & therapy.

Reslizumab for pediatric eosinophilic esophagitis.

G. Walsh, 2010, Immunotherapy.

Therapeutic Potential of Targeting Interleukin 5 in Asthma

G. Walsh, 2013, BioDrugs.

Integrin α4β7 mediates human eosinophil interaction with MAdCAM‐1, VCAM‐1 and fibronectin

F. Symon, A. Wardlaw, G. Walsh, 1996, Immunology.

Allergy and Asthma: Small Molecule Approaches

G. Walsh, 2008 .

Eosinophil–epithelial cell interactions: a special relationship?

G. Walsh, 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.

A. Wardlaw, A. Kay, A. Hartnell, 1991, International archives of allergy and applied immunology.

Eosinophil granule proteins and their role in disease

G. Walsh, 2001, Current opinion in hematology.

Disodium cromoglycate inhibits activation of human inflammatory cells in vitro.

A. Kay, H. Richerson, M. Carroll, 1987, The Journal of allergy and clinical immunology.

Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation

A. Kay, O. Cromwell, R. Moqbel, 1985, Nature.

Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells.

A. Kay, O. Cromwell, R. Moqbel, 1990, Blood.

Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor.

F. Symon, A. Wardlaw, G. Willars, 1996, Blood.

Human eosinophils prefernentially surivive on tissue fibronectin compared with plasama fibronection

F. Symon, A. Wardlaw, G. Walsh, 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils.

A. Wardlaw, F. Levi-Schaffer, G. Dewson, 1998, Journal of immunological methods.

Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.

A. Kay, G. Walsh, 1986, Clinical and experimental immunology.

Effects of cetirizine on human eosinophil and neutrophil activation in vitro.

A. Kay, R. Moqbel, A. Hartnell, 1991, International archives of allergy and applied immunology.

Monoclonal Antibody-Based Therapy for Eosinophilic Oesophagitis

G. Walsh, 2016, EMJ Gastroenterology.

Sputum eosinophil apoptotic rate is positively correlated to exhaled nitric oxide in children

S. Turner, G. Walsh, M. Blaylock, 2008, Pediatric pulmonology.

Effect of disodium cromoglycate on activation of human eosinophils and neutrophils following reversed (anti‐IgE) anaphylaxis

R. Moqbel, G. Walsh, A. Macdonald, 1986, Clinical allergy.

Membrane receptor‐mediated apoptosis and caspase activation in the differentiated EoL‐1 eosinophilic cell line

D. Sexton, G. Walsh, M. Blaylock, 2004, Journal of leukocyte biology.

Biologics for asthma and allergy

G. Walsh, 2017, Current opinion in otolaryngology & head and neck surgery.

Effects of nedocromil sodium (Tilade®) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells

A. Wardlaw, A. Kay, O. Cromwell, 1988, Allergy.

The effect of platelet-activating factor on IgE binding to, and IgE-dependent biological properties of, human eosinophils.

A. Wardlaw, A. Kay, R. Moqbel, 1990, Immunology.

Autophagy and Asthma

G. Walsh, G. M. Walsh, M. Farooq, 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Targeting eosinophils in asthma: current and future state of cytokine- and chemokine-directed monoclonal therapy

G. Walsh, 2010, Expert review of clinical immunology.

Enhancement of leukocyte cytotoxicity after exercise-induced asthma.

S. Durham, A. Kay, M. Carroll, 1986, The American review of respiratory disease.

New Insights into the Second Generation Antihistamines

J. Tillement, H. Timmerman, N. Frossard, 2012, Drugs.

Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?

G. Walsh, 2008, Trends in pharmacological sciences.

Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstriction.

S. Durham, A. Kay, M. Carroll, 1985, The Journal of allergy and clinical immunology.

Eosinophil–epithelial cell interactions: an important facet of asthmatic inflammation

D. Sexton, G. Walsh, 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Molecular Biology of Eosinophils: Introduction.

H. Rosenberg, Paige Lacy, G. Walsh, 2021, Methods in molecular biology.

colony-stimulating factor eosinophils cultured with granulocyte-macrophage Ligation of CD69 induces apoptosis and cell death in human

F. Symon, A. Wardlaw, G. Willars, 2011 .

Ligation of CD 69 Induces Apoptosis and Cell Death in Human Eosinophils Cultured With Granulocyte-Macrophage Colony-Stimulating Factor

Andrew, G. Willars, Fiona, 2002 .

The anti‐inflammatory effects of the second‐generation antihistamines

G. Walsh, 2000 .

EOSINOPHIL APOPTOSIS: MECHANISMS and CLINICAL RELEVANCE IN ASTHMATIC and ALLERGIC INFLAMMATION

G. Walsh, 2000, British journal of haematology.

The clinical relevance of the anti‐inflammatory properties of antihistamines

G. Walsh, 2000, Allergy.

Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin.

A. Wardlaw, G. Walsh, 1997, The Journal of allergy and clinical immunology.

Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent

F. Symon, A. Wardlaw, S. Watson, 1994, The Journal of experimental medicine.

Second-Generation Antihistamines in Asthma Therapy

G. Walsh, 2002, American journal of respiratory medicine : drugs, devices, and other interventions.

Novel cytokine-directed therapies for asthma.

G. Walsh, 2011, Discovery medicine.

Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes.

A. Kay, O. Cromwell, R. Moqbel, 1988, The Journal of allergy and clinical immunology.

Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin- and phosphatidylserine receptor-dependent mechanisms: a process upregulated by dexamethasone.

D. Sexton, G. Walsh, M. Blaylock, 2001, The Journal of allergy and clinical immunology.

Antihistamines (H1 receptor antagonists)

G. Walsh, 2010 .

Chapter 15 – Antihistamines (H1 Receptor Antagonists)

G. Walsh, 2009 .

A review of the role of levocetirizine as an effective therapy for allergic disease

G. Walsh, 2008, Expert opinion on pharmacotherapy.

Antihistamines (H 1 receptor antagonists)

G. Walsh, 2005 .

Anti‐inflammatory properties of antihistamines: an update

G. Walsh, 2005 .

Airway epithelial cytokine responses in childhood wheeze are independent of atopic status.

P. Helms, G. Walsh, C. McDougall, 2015, Respiratory medicine.

[Not Available].

G. Walsh, 2007, Therapeutics and clinical risk management.

In Vitro Effects of Chemotactic Factors on Eosinophil Fc and Complement Receptor Expression

A. Wardlaw, A. Kay, R. Moqbel, 1987, Acta paediatrica Japonica : Overseas edition.

Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C.

A. Kay, A. Mallet, O. Cromwell, 1985, International journal of immunopharmacology.

Eosinophils from patients with asthma express higher levels of the pan‐leucocyte receptor CD45 and the isoform CD45RO

B. Lipworth, O. J. Dempsey, G. Walsh, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Ligation of CD45 and the isoforms CD45RA and CD45RB accelerates the rate of constitutive apoptosis in human eosinophils.

D. Sexton, G. Walsh, M. Blaylock, 1999, The Journal of allergy and clinical immunology.

The Requirements for Transferrin‐Dependent Adherence of Human Granulocytes to Pollen Grains

A. Kay, R. Moqbel, G. Walsh, 1986, Allergy.

Role of chemical mediators after antigen and exercise challenge in children with asthma.

T. Nagakura, M. Okuma, G. Walsh, 1988, The Journal of allergy and clinical immunology.

The effects of cetirizine on the function of inflammatory cells involved in the allergic response

G. Walsh, 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Eosinophil Interactions with Extracellular Matrix Proteins

A. Wardlaw, G. Walsh, 2020 .

Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils.

A. Kay, R. Moqbel, A. Hartnell, 1990, Immunology.

Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils.

A. Kay, G. Walsh, 1984, Clinical and experimental immunology.

Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions.

G. Walsh, 2009, Current opinion in molecular therapeutics.

Primary Paediatric Bronchial Airway Epithelial Cell in Vitro Responses to Environmental Exposures

S. Semple, S. Turner, G. Devereux, 2016, International journal of environmental research and public health.

A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule‐1 under flow conditions

G. Walsh, P. Wu, G. M. Walsh, 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Leucocyte activation initiated by IgE-dependent mechanisms in relation to helminthic parasitic disease and clinical models of asthma.

S. Durham, A. Kay, O. Cromwell, 1985, International archives of allergy and applied immunology.

Novel therapies for asthma--advances and problems.

G. Walsh, 2005, Current pharmaceutical design.

INHIBITION OF HUMAN GRANULOCYTE ACTIVATION BY NEDOCROMIL SODIUM

A. Kay, R. Moqbel, G. Walsh, 1986 .

The Role of Adhesion in Eosinophil Accumulation and Activation in Asthma

A. Wardlaw, A. Kay, A. Hartnell, 2019, Eosinophils in Allergy and Inflammation.

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

G. Walsh, 2010, Current opinion in investigational drugs.

ENHANCED NEUTROPHIL AND MONOCYTE CYTO-TOXICITY AFTER EXERCISE INDUCED ASTHMA

S. Durham, A. Kay, M. Carroll, 1985 .

Enhancement of human neutrophil complement receptors: a comparison of the rosette technique with the uptake of radio-labelled anti-CR1 monoclonal antibody.

M. Walport, A. Kay, H. Richerson, 1985, Clinical and experimental immunology.

Antagonism of eosinophil accumulation in asthma.

G. Walsh, 2010, Recent patents on inflammation & allergy drug discovery.

Mepolizumab and eosinophil-mediated disease.

G. Walsh, 2009, Current medicinal chemistry.

Montelukast inhibition of resting and GM‐CSF‐stimulated eosinophil adhesion to VCAM‐1 under flow conditions appears independent of cysLT1R antagonism

A. J. Robinson, Dmitry Kashanin, D. Kashanin, 2008, Journal of leukocyte biology.

Allergy, Asthma & Clinical Immunology Open Access the Anti-inflammatory Effects of Levocetirizine -are They Clinically Relevant or Just an Interesting Additional Effect?

G. Walsh, 2022 .

Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update

G. Walsh, 2020, Expert opinion on biological therapy.

Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma – an update

G. Walsh, 2017, Expert review of clinical immunology.

Adhesion Interactions Involved in Eosinophil Migration through Vascular Endothelium

F. Symon, A. Wardlaw, G. Walsh, 1996, Annals of the New York Academy of Sciences.

Eosinophil adhesion in allergic inflammation.

A J Wardlaw, F S Symon, G M Walsh, 1994, The Journal of allergy and clinical immunology.

An update on emerging drugs for asthma

G. Walsh, 2012, Expert opinion on emerging drugs.

Phagocytosis of apoptotic eosinophils but not neutrophils by bronchial epithelial cells

G. Walsh, M. Blaylock, D. Sexton, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effective antigen presentation to helper T cells by human eosinophils

A. Ghaemmaghami, R. Barker, M. Vickers, 2016, Immunology.

Culture of Airway Epithelial Cells from Neonates Sampled within 48-Hours of Birth

S. Turner, G. Devereux, P. Danielian, 2013, PloS one.

Nasal and bronchial airway epithelial cell mediator release in children

S. Turner, G. Devereux, G. Walsh, 2012, Pediatric pulmonology.

Biotherapeutics: Recent Developments using Chemical and Molecular Biology. Edited by Lyn H. Jones, Andrew J. McKnight

G. Walsh, 2014 .

Treatment options for postmenopausal osteoporosis

G. Walsh, 2012, Therapeutics and Clinical Risk Management.

Eosinophils: Methods and Protocols

G. Walsh, 2014 .

Mepolizumab-based therapy in asthma: an update

G. Walsh, 2015, Current opinion in allergy and clinical immunology.

Pro‐inflammatory mediator responses from neonatal airway epithelial cells and early childhood wheeze

M. Shields, S. Turner, U. Power, 2018, Pediatric pulmonology.

Fluvastatin and lovastatin inhibit granulocyte macrophage–colony stimulating factor‐stimulated human eosinophil adhesion to inter‐cellular adhesion molecule‐1 under flow conditions

A. J. Robinson, D. Kashanin, G. Walsh, 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Targeting airway inflammation: novel therapies for the treatment of asthma.

G. Walsh, 2006, Current medicinal chemistry.

Editorial

G. Walsh, 2007, Biotechnology Letters.

Mechanisms of eosinophil and basophil migration

F. Symon, A. Wardlaw, G. Walsh, 1994, Allergy.

Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity.

M. Walport, A. Kay, H. Richerson, 1987, Clinical and experimental immunology.

Eosinophils

G. Walsh, 2014, Methods in Molecular Biology.

[Not Available].

G. Walsh, 2007, Therapeutics and clinical risk management.

Editorial Foreword

G. Walsh, 2006, Therapeutics and clinical risk management.